All-Star forward Chris Bosh has had a difficult few years. After dealing with potentially life-threatening blood clots and putting his career on hiatus, Bosh’s time with Miami appears to be at an end. The team’s medical staff was never able to fully clear Bosh to return to the court, but that has not stopped him from attempting a comeback. But according to NBA.com’s David Aldridge, NBA executives are not too confident in such a return.
Aldridge cites several anonymous sources that say Bosh should garner interest on name alone, but will prove to be too risky both physically and financially. One Eastern Conference executive says that “there will surely be interest, but it may be hard to find a doctor that will clear him”. A Western Conference executive voiced a similar stance, saying “there will be interest, but the health risks outweigh the upside for most organizations”.
Another Western Conference source had a more lengthy response about Bosh’s future. “I don’t see how medical people will want to sign off and clear him. Unless something has changed with his health recently … I don’t know of a team that would want to take that type of a risk. If something were to tragically happen, it’s hard to recover form that. Very unfortunate.”
“Miami had about $50 million reasons for him to play and could not get a doctor to clear him,” another Western Conference source tells Aldridge. “Very unlikely the answer will be different at a team with $0 million reasons for him to play”.
If Chris Bosh can come back to some level resembling his former self, he is clearly an impact player. However, it is far too risky to assume he will reach that status. The Chicago Bulls showed some interest in Bosh this past March, but those rumors never materialized. Bosh has also said he wants to reunite with LeBron James or Dwyane Wade if he does comeback, but health should be the primary focus. Playing professional basketball is treasured by all fortunate enough to play, but nobody can put a price on good health.
